Abstract Selecting the optimal biologic or targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) for patients with rheumatoid arthritis remains challenging. We developed and externally validated a causal inference framework combining double machine learning-based causal forests with guideline-derived safety constraints.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yo
Contact Yo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack